Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (111-120 of 685) with videos related to

Pageof 69
Sort By:
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Cancer|March 26, 2010
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsIsabelle Bedrosian, Gildy V Babiera, Elizabeth A Mittendorf, et al.
Future Oncology (London, England)|October 28, 2024
Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancerFunda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Post-Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid TumorsVicky Makker, Jung-Yun Lee, Do-Youn Oh, et al.
Annals of Surgical Oncology|June 19, 2010
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patientsCarolyn Hall, Savitri Krishnamurthy, Ashutosh Lodhi, et al.
JAMA Network Open|May 20, 2022
Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing GuidelinesTimothy A Yap, Arya Ashok, Jessica Stoll, et al.
American Journal of Surgery|September 19, 2006
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinomaThao N Vo, Funda Meric-Bernstam, Min Yi, et al.
Journal of the National Cancer Institute|October 29, 2011
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancersChristos Hatzis, Hongxia Sun, Hui Yao, et al.
Nature Communications|August 11, 2017
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancerRuli Gao, Charissa Kim, Emi Sei, et al.
The Journal of Surgical Research|June 12, 2013
Career track of Society of University Surgeons Resident Research Award recipientsBurhan Hassan, Elmer Bernstam, O Joe Hines, et al.
Pageof 69

Showing results (111-120 of 685) with videos related to

Sort By:
Pageof 69
Investigational New Drugs|October 1, 2016
Incidence of infusion reactions to anti-neoplastic agents in early phase clinical trials: The MD Anderson Cancer Center experienceManojkumar Bupathi, Joud Hajjar, Stacie Bean, et al.
Cancer|March 26, 2010
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsIsabelle Bedrosian, Gildy V Babiera, Elizabeth A Mittendorf, et al.
Future Oncology (London, England)|October 28, 2024
Plain language summary: an analysis of the safety of futibatinib treatment in people with different types of cancerFunda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2026
Post-Hoc Analysis of the Phase II DESTINY-PanTumor02 Study: Local and Central HER2 IHC Concordance and Trastuzumab Deruxtecan Efficacy by HER2 IHC Status in HER2-Expressing Solid TumorsVicky Makker, Jung-Yun Lee, Do-Youn Oh, et al.
Annals of Surgical Oncology|June 19, 2010
Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patientsCarolyn Hall, Savitri Krishnamurthy, Ashutosh Lodhi, et al.
JAMA Network Open|May 20, 2022
Prevalence of Germline Findings Among Tumors From Cancer Types Lacking Hereditary Testing GuidelinesTimothy A Yap, Arya Ashok, Jessica Stoll, et al.
American Journal of Surgery|September 19, 2006
Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinomaThao N Vo, Funda Meric-Bernstam, Min Yi, et al.
Journal of the National Cancer Institute|October 29, 2011
Effects of tissue handling on RNA integrity and microarray measurements from resected breast cancersChristos Hatzis, Hongxia Sun, Hui Yao, et al.
Nature Communications|August 11, 2017
Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancerRuli Gao, Charissa Kim, Emi Sei, et al.
The Journal of Surgical Research|June 12, 2013
Career track of Society of University Surgeons Resident Research Award recipientsBurhan Hassan, Elmer Bernstam, O Joe Hines, et al.
Pageof 69